Ledipasvir / Sofosbuvir

Details

Files

Generic Name:

Ledipasvir / Sofosbuvir

Project Status:

Complete

Therapeutic Area:

Hepatitis C, chronic

Manufacturer:

Gilead Sciences Canada Inc.

Call for patient/clinician input open:

August 18, 2014

Brand Name:

Harvoni

Project Line:

Reimbursement Review

Project Number:

SR0395-000

Call for patient/clinician input closed:

October 7, 2014

NOC Status at Filing:

Pre NOC

Performance Metric:

Achieved

Submission Type:

Initial

Indications:

Hepatitis C, chronic

Recommendation Type:

List with criteria/condition

Final Recommendation:

March 18, 2015

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Clinical Report View PDF

Pharmacoeconomic Report View PDF

Patient Group Input Submissions View PDF

Last Updated : September 15, 2014